Cargando…

Asymptomatic leishmaniasis in a patient with relapsed multiple myeloma

Detalles Bibliográficos
Autores principales:	Rubio, Lucia, Jimenez, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Haematology Images
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175674/ https://www.ncbi.nlm.nih.gov/pubmed/35844725 http://dx.doi.org/10.1002/jha2.217

Ejemplares similares

IgG kappa multiple myeloma with isolated central nervous system relapse
por: Xu, Ke, et al.
Publicado: (2022)

A rare case of relapsed multiple myeloma with aberrant T‐cell antigen expression and skin plasmacytomas
por: Lecat, Catherine S.Y., et al.
Publicado: (2021)

Giant multinucleated plasma cells in relapsed plasma cell myeloma
por: Ghattas, Sylvia, et al.
Publicado: (2020)

Lymphoplasmacytic variant of multiple myeloma
por: Johansen, Silje, et al.
Publicado: (2022)

Multiple myeloma presenting as a massive osteolytic lesion at the clivus
por: Sousa, Domingos, et al.
Publicado: (2020)

Plasmacytoma/multiple myeloma type posttransplant lymphoproliferative disorder
por: Claushuis, Theodora A.M., et al.
Publicado: (2022)

A case of multiple myeloma with plasma cell cannibalism and cytophagocytosis
por: Varghese, Julia, et al.
Publicado: (2021)

Gastric involvement: A rare extramedullary location of multiple myeloma
por: Pedrosa, Cláudia, et al.
Publicado: (2020)

Multiple myeloma with G‐CSF production mimicking chronic neutrophilic leukemia
por: Ureshino, Hiroshi, et al.
Publicado: (2021)

Triphenotypic multiple myeloma expressing kappa or lambda light chain or both
por: Liu, Yang, et al.
Publicado: (2013)

A case of multiple myeloma with AL amyloidosis showing giant Russel bodies
por: Mcphaden, Heather, et al.
Publicado: (2023)

Seborrheic keratosis (Leser‐Trélat sign) in multiple myeloma signalling disease progression
por: Jenkins, Christopher, et al.
Publicado: (2020)

Isolated bone marrow amyloid light chain amyloidosis coexisting with multiple myeloma
por: Álamo Moreno, José R., et al.
Publicado: (2023)

A case of multiple myeloma with markedly straight lines or curved deep groove nuclei
por: He, Chang, et al.
Publicado: (2021)

Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results
por: Richardson, Paul G., et al.
Publicado: (2018)

Crystal‐storing histiocytes and plasma cells, crystalline corneal deposits and atypical MRI lesions in multiple myeloma
por: Khakwani, Muhammad, et al.
Publicado: (2022)

Development and validation of a novel risk stratification algorithm for relapsed multiple myeloma
por: Hájek, Roman, et al.
Publicado: (2019)

A phase 1/2 study of carfilzomib in Japanese patients with relapsed and/or refractory multiple myeloma
por: Watanabe, Takashi, et al.
Publicado: (2016)

Myeloma‐induced leucocytoclastic vasculitis
por: De Abrew, Kanchana, et al.
Publicado: (2020)

Secondary effects after belantamab treatment: A new anti‐B‐cell maturation antigen monoclonal antibody for multiple myeloma
por: Garrido Paniagua, Sara, et al.
Publicado: (2021)

Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma
por: Chen, Christine, et al.
Publicado: (2009)

Dutcher bodies in an IgA‐myeloma patient harbouring the FGFR3/IGH fusion
por: Manabe, Masahiro, et al.
Publicado: (2023)

Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study
por: Yimer, Habte, et al.
Publicado: (2019)

Acquired platelet dysfunction in newly diagnosed myeloma
por: Mortimer, Joshua, et al.
Publicado: (2021)

Plasmablastic myeloma progressed to plasma cell leukaemia
por: Xu, Ke, et al.
Publicado: (2021)

Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma
por: Kumar, Shaji, et al.
Publicado: (2017)

Lymphoid morphology, hyperviscosity and extensive immunoglobulin deposits in myeloma
por: Sehgal, Tushar, et al.
Publicado: (2022)

Characterisation and prognostic impact of immunoparesis in relapsed multiple myeloma
por: Chakraborty, Rajshekhar, et al.
Publicado: (2020)

Efficacy of retreatment with immunomodulatory drugs and proteasome inhibitors following daratumumab monotherapy in relapsed and refractory multiple myeloma patients
por: Oostvogels, Rimke, et al.
Publicado: (2018)

Phase 1 study of selinexor plus carfilzomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma
por: Jakubowiak, Andrzej J., et al.
Publicado: (2019)

Neurolymphomatosis as a manifestation of relapsed diffuse large B‐cell lymphoma
por: Okamura‐Shiki, Ikue, et al.
Publicado: (2022)

The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long‐term follow‐up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open‐label, phase 3 trial
por: Cook, Gordon, et al.
Publicado: (2019)

Carfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: secondary analysis from the phase 3 ASPIRE study
por: Dimopoulos, Meletios A., et al.
Publicado: (2017)

Extranodal relapse of anaplastic large cell lymphoma around the Achilles tendon masquerading as a posttraumatic hematoma
por: Joshi, Kajal, et al.
Publicado: (2021)

Selinexor, daratumumab, and dexamethasone in patients with relapsed or refractory multiple myeloma
por: Gasparetto, Cristina, et al.
Publicado: (2020)

Multiple myeloma: patient outcomes in real‐world practice
por: Yong, Kwee, et al.
Publicado: (2016)

Sotatercept in patients with osteolytic lesions of multiple myeloma
por: Abdulkadyrov, Kudrat M, et al.
Publicado: (2014)

Subgroup analysis of ICARIA‐MM study in relapsed/refractory multiple myeloma patients with high‐risk cytogenetics
por: Harrison, Simon J., et al.
Publicado: (2021)

Daratumumab combined with dexamethasone and lenalidomide or bortezomib in relapsed/refractory multiple myeloma (RRMM) patients: Report from the multiple myeloma GIMEMA Lazio group
por: Fazio, Francesca, et al.
Publicado: (2022)

Multiple thrombosis during eltrombopag therapy
por: Shimazu, Yutaka, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jcb1hunj2ksck4tlb95qoquojh